Sanofi: Asthma trials
The registry lists 37 Asthma studies with Sanofi as lead sponsor. 3 are open to participants now and 14 have results posted.
Phase 1 1Phase 2 11Phase 3 16Phase 4 4No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical PracticeRecruitingNCT07556159
- Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With AsthmaEnrolling by invitationNCT06609239Phase 2
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Enrolling by invitationNCT06191315Phase 3
- Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe AsthmaCompletedNCT05421598Phase 2Results posted
- EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 PatientsCompletedNCT04998604Phase 4Results posted
- A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent AsthmaCompletedNCT04502862Phase 4Results posted
- The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe AsthmaCompletedNCT04400318Phase 4Results posted
- Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)CompletedNCT03620747Phase 3Results posted
- Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)CompletedNCT03560466Phase 3Results posted
- Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma ParticipantsCompletedNCT03387852Phase 2Results posted
- Evaluation of Dupilumab in Children With Uncontrolled AsthmaCompletedNCT02948959Phase 3Results posted
- Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With AsthmaCompletedNCT02573233Phase 2Results posted
- Evaluation of Dupilumab in Patients With Severe Steroid Dependent AsthmaCompletedNCT02528214Phase 3Results posted
- Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)CompletedNCT02414854Phase 3Results posted
- Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)CompletedNCT02134028Phase 3Results posted
- An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled AsthmaCompletedNCT01854047Phase 2Results posted
- Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic AsthmaCompletedNCT01312961Phase 2Results posted
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaActive, not recruitingNCT06676319Phase 2
- Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe AsthmaCompletedNCT06102005Phase 2
- An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe AsthmaCompletedNCT06064526
- Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical StudyTerminatedNCT06033833Phase 2
- A Study to Evaluate the Quality of Life in Male and Female Adult Participants With Severe Asthma Treated With Dupilumab in a Real-world SettingCompletedNCT06018441
- First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic ParticipantsCompletedNCT05366764Phase 1
- Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe AsthmaCompletedNCT05104892Phase 2
- Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe AsthmaActive, not recruitingNCT05097287Phase 4
- A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)CompletedNCT05070663
- Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)CompletedNCT04550962
- Efficacy and Safety Study of Dupilumab in Patients With Persistent AsthmaCompletedNCT03782532Phase 3
- TELICAST : Telithromycin in Acute Exacerbations of AsthmaCompletedNCT00273520Phase 3
- Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent AsthmaCompletedNCT00270348Phase 3
- Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent AsthmaCompletedNCT00254956Phase 3
- Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent AsthmaCompletedNCT00174746Phase 2
- Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled CorticosteroidCompletedNCT00174733Phase 3
- Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.CompletedNCT00174720Phase 3
- Long-Term Safety Performance of Fexofenadine in AsthmaCompletedNCT00045955Phase 3
- Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCompletedNCT00044824Phase 3
- Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCompletedNCT00044811Phase 3